Altimmune, Inc.
ALT
$3.33
-$0.04-1.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.16% | 17.53% | -43.88% | 14.14% | -13.13% |
| Total Depreciation and Amortization | 0.00% | -11.54% | -3.70% | -10.00% | 3.45% |
| Total Amortization of Deferred Charges | -- | -- | -251.33% | 94.83% | -- |
| Total Other Non-Cash Items | -33.38% | -19.11% | 28.83% | 8.30% | 20.77% |
| Change in Net Operating Assets | -114.21% | -155.03% | 2.41% | 848.52% | -746.58% |
| Cash from Operations | -15.66% | -7.68% | -63.47% | 38.52% | -14.90% |
| Capital Expenditure | -52.38% | -2,000.00% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5,934.64% | 95.36% | 46.99% | -247.67% | 2,082.30% |
| Cash from Investing | -5,901.17% | 95.34% | 46.99% | -247.69% | 2,082.10% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 166.84% | 28.57% | 55.39% | 4.31% | 8.92% |
| Repurchase of Common Stock | -- | -2,680.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -371.91% | 81.84% | -52.17% | 16.36% | -218.18% |
| Cash from Financing | 168.97% | -3.27% | 106.18% | -24.68% | 53.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.25% | 408.09% | 85.66% | -190.95% | 1,000.35% |